Biogen

BYOOVIZ - Cost

Last Updated: April 1st, 2024

HCPCS:

Q5124

HCPCS Code Descriptor:

Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg

Medicare Payment Limit:

The BYOOVIZ Medicare Payment Limit is $175.058

Average Sale Price:

BYOOVIZ ASP cost available once logged in. Byooviz is a biosimilar drug making the ASP calculation more complex. Byooviz's ASP is based on the average sale price of its biosimilar reference drug.

Medicare Co-Insurance Percentage:

The BYOOVIZ Medicare Co-insurance percentage is 20%. BYOOVIZ's Medicare Co-insurance amount is $35.01 per HCPCS unit.

APC Code:

The Byooviz APC Code is: 9017

APC Payment Limit:

The APC Payment Limit for BYOOVIZ is available. Login to view.

Byooviz Cost Information:

BYOOVIZ, became effective on January 1, 2023 and is aligned to Q Code: Q5124. Between 2023 and 2024, prices remained level amongst AWP and WAC. However, ASP declined by nearly 25% during this time.

ACCESS PRICING AND MORE BY REGISTERING

Byooviz’s wholesale acquisition cost (WAC) information was last updated on:
July 1, 2022
Byooviz’s average wholesale price (AWP) information was last updated on:
July 1, 2022

Byooviz Cost Graph: